Literature DB >> 29972578

Atrial fibrillation in acute Chagas disease acquired via oral transmission: a case report.

Paulo Fernando Pimenta de Souza1, Rosane Cheble Domingues Pine2, Francisco Lúzio de Paula Ramos3, Ana Yecê das Neves Pinto3.   

Abstract

Atrial fibrillation (AF), a type of supraventricular arrhythmia increases the risk of thromboembolism. Chagas disease has been reported in the Brazilian Amazon region over approximately 20 years. Cardiac abnormalities are recorded in at least 50% of patients and among these, 3.3% develop AF. We describe a case of a 41-year-old man from Muaná, Pará State, who reported a 30-day history of a febrile illness. Acute Chagas disease was confirmed, and an electrocardiogram revealed AF. He was treated with antiparasitic and anti-arrhythmic drugs, beta blockers, and anticoagulants. Reversion to sinus rhythm was observed at his 9-month follow-up.

Entities:  

Mesh:

Year:  2018        PMID: 29972578     DOI: 10.1590/0037-8682-0296-2017

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  2 in total

1.  Cardiovascular Statistics - Brazil 2020.

Authors:  Gláucia Maria Moraes de Oliveira; Luisa Campos Caldeira Brant; Carisi Anne Polanczyk; Andreia Biolo; Bruno Ramos Nascimento; Deborah Carvalho Malta; Maria de Fatima Marinho de Souza; Gabriel Porto Soares; Gesner Francisco Xavier Junior; M Julia Machline-Carrion; Marcio Sommer Bittencourt; Octavio M Pontes Neto; Odilson Marcos Silvestre; Renato Azeredo Teixeira; Roney Orismar Sampaio; Thomaz A Gaziano; Gregory A Roth; Antonio Luiz Pinho Ribeiro
Journal:  Arq Bras Cardiol       Date:  2020-09       Impact factor: 2.667

2.  Oral Route Driven Acute Trypanosoma cruzi Infection Unravels an IL-6 Dependent Hemostatic Derangement.

Authors:  Dina Antunes; Alessandro Marins-Dos-Santos; Mariana Tavares Ramos; Barbara Angelica S Mascarenhas; Carlos José de Carvalho Moreira; Désio Aurélio Farias-de-Oliveira; Wilson Savino; Robson Q Monteiro; Juliana de Meis
Journal:  Front Immunol       Date:  2019-05-14       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.